Viewing StudyNCT00356889



Ignite Creation Date: 2024-05-05 @ 4:57 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00356889
Status: COMPLETED
Last Update Posted: 2014-05-28
First Post: 2006-07-26

Brief Title: Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-05
Start Date Type: None
Primary Completion Date: 2008-10
Primary Completion Date Type: ACTUAL
Completion Date: 2010-06
Completion Date Type: ACTUAL
First Submit Date: 2006-07-26
First Submit QC Date: July 26 2006
Study First Post Date: 2006-07-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2013-05-20
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-05-12
Last Update Post Date: 2014-05-28
Last Update Post Date Type: ESTIMATED